Genome Quebec Names Former Glaxo Wellcome Exec As CEO | GenomeWeb

NEW YORK, June 12 - Genome Quebec, the provincial arm of the Canadian genomics research organization Genome Canada, has appointed Paul L'Archevêque to the position of president and chief executive officer, the organization said Tuesday. 

L'Archevêque, a former vice president for marketing at Glaxo Wellcome, now GlaxoSmithKline, said in a statement he would strive to bridge the private and public sectors in raising money and awareness of genomics in Quebec. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."